Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials

Clowse Megan E. B. and Wallace Daniel J. and Furie Richard A. and Petri Michelle A. and Pike Marilyn C. and Leszczynski Piotr and Neuwelt C. Michael and Hobbs Kathryn and Keiserman Mauro and Duca Liliana and Kalunian Kenneth C. and EMBODY Investigator Group and Gasztonyi Beáta and Géher Pál and Kemény Lajos and Kiss Emese and Kovács László and Szűcs Gabriella and et al. (kollab. közrem.): Efficacy and Safety of Epratuzumab in Moderately to Severely Active Systemic Lupus Erythematosus: Results From Two Phase III Randomized, Double-Blind, Placebo-Controlled Trials.
ARTHRITIS & RHEUMATOLOGY, 69 (2). pp. 362-375. ISSN 2326-5191 (2017)

[thumbnail of 3217512_Clowse.pdf]
Preview
Text
3217512_Clowse.pdf - Published Version

Download (360kB) | Preview
Item Type: Journal Article
Szerzők száma: 295
Journal or Publication Title: ARTHRITIS & RHEUMATOLOGY
Date: 2017
Volume: 69
Number: 2
Page Range: pp. 362-375
ISSN: 2326-5191
Publisher: John Wiley and Sons, Inc.
Faculty/Unit: Faculty of Medicine
Institution: Szegedi Tudományegyetem
Language: English
MTMT rekordazonosító: 3217512
DOI azonosító: https://doi.org/10.1002/art.39856
Date Deposited: 2018. Jan. 17. 10:06
Last Modified: 2022. Aug. 11. 11:07
URI: http://publicatio.bibl.u-szeged.hu/id/eprint/12731
Web of Science® Times Cited: 154 View citing articles in Web of Science®

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year